Aligos Therapeutics, Inc.
ALGS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001799448
No open-market purchases or sales by Aligos Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $13.2M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
13F holders, Q3 2022
Institutional positions in Aligos Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 52
- −8 vs. Q2 2022
- Shares held
- 27.6M
- −2.16M (−7.2%) vs. Q2 2022
- Total value
- $30.4M
- −$5.66M (−15.7%) vs. Q2 2022
- New holders
- 5
- 12 more added
- Sold out
- 13
- 17 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALGS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $13.2M |
| Q1 2026 | 35 | $20.6M |
| Q4 2025 | 41 | $26.2M |
| Q3 2025 | 33 | $26.0M |
| Q2 2025 | 37 | $19.5M |
| Q1 2025 | 35 | $27.1M |
| Q4 2024 | 34 | $64.5M |
| Q3 2024 | 27 | $14.7M |
| Q2 2024 | 49 | $16.6M |
| Q1 2024 | 49 | $45.3M |
| Q4 2023 | 40 | $30.1M |
| Q3 2023 | 36 | $19.2M |
| Q2 2023 | 41 | $25.5M |
| Q1 2023 | 46 | $23.9M |
| Q4 2022 | 39 | $25.3M |
| Q3 2022 | 52 | $30.4M |
| Q2 2022 | 60 | $36.0M |
| Q1 2022 | 76 | $68.4M |
| Q4 2021 | 71 | $390.4M |
| Q3 2021 | 68 | $483.9M |
| Q2 2021 | 58 | $550.5M |
| Q1 2021 | 52 | $612.4M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Aligos Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cubist Systematic Strategies, LLC | 26 | $0 | 0.00% | −3,836−99.3% | Reduced |
| Wells Fargo & Company | 169 | $0 | 0.00% | +44+35.2% | Added |
| Royal Bank of Canada | 13 | $0 | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 115 | $0 | 0.00% | 00.0% | Unchanged |
| Newbridge Financial Services Group, Inc. | 37 | $0 | 0.00% | 00.0% | Unchanged |
| China Universal Asset Management Co., Ltd. | 372 | $0 | 0.00% | +372 | New |
| Citigroup Inc | 563 | $1.00K | 0.00% | −1,049−65.1% | Reduced |
| FMR LLC | 1,013 | $1.00K | 0.00% | +532+110.6% | Added |
| Capital Advisors, Ltd. LLC | 667 | $1.00K | 0.00% | −220−24.8% | Reduced |
| Federated Hermes, Inc. | 2,017 | $2.00K | 0.00% | +2,017 | New |
| JPMorgan Chase & Co | 3,802 | $5.00K | 0.00% | +2,230+141.9% | Added |
| Tower Research Capital LLC (TRC) | 8,062 | $9.00K | 0.00% | −10,577−56.7% | Reduced |
| Advisor Group Holdings, Inc. | 8,000 | $9.00K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 10,282 | $11.0K | 0.00% | −42,331−80.5% | Reduced |
| Gsa Capital Partners LLP | 10,513 | $12.0K | 0.00% | −10,205−49.3% | Reduced |
| Balyasny Asset Management LLC | 11,999 | $13.0K | 0.00% | +11,999 | New |
| Goldman Sachs Group Inc | 14,043 | $15.0K | 0.00% | −84,916−85.8% | Reduced |
| Qube Research & Technologies Ltd | 16,031 | $18.0K | 0.00% | −2,658−14.2% | Reduced |
| HarbourVest Partners LLC | 18,783 | $21.0K | 0.01% | 00.0% | Unchanged |
| Bailard, Inc. | 19,400 | $21.0K | 0.00% | +19,400 | New |
| D. E. Shaw & Co., Inc. | 31,568 | $35.0K | 0.00% | −123,300−79.6% | Reduced |
| Northern Trust Corp | 32,604 | $36.0K | 0.00% | 00.0% | Unchanged |
| Brinker Capital Investments, LLC | 37,981 | $42.0K | 0.00% | −6,668−14.9% | Reduced |
| Oasis Management Co Ltd. | 45,797 | $50.0K | 0.01% | 00.0% | Unchanged |
| Ergoteles LLC | 52,889 | $58.0K | 0.00% | −50,811−49.0% | Reduced |
| State Street Corp | 60,823 | $67.0K | 0.00% | 00.0% | Unchanged |
| Deutsche Bank AG | 71,290 | $78.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 73,295 | $80.0K | 0.00% | −85,644−53.9% | Reduced |
| Rockefeller Capital Management L.P. | 77,499 | $85.0K | 0.00% | +77,499 | New |
| Bridgeway Capital Management, LLC | 79,000 | $87.0K | 0.00% | +22,000+38.6% | Added |
| HRT Financial LP | 101,772 | $111.0K | 0.00% | −34,814−25.5% | Reduced |
| Two Sigma Advisers, LP | 117,500 | $129.0K | 0.00% | +5,300+4.7% | Added |
| Two Sigma Investments, LP | 124,426 | $137.0K | 0.00% | −70,986−36.3% | Reduced |
| Geode Capital Management, LLC | 190,418 | $209.0K | 0.00% | 00.0% | Unchanged |
| New York Life Investment Management LLC | 234,100 | $258.0K | 0.00% | +17,198+7.9% | Added |
| Millennium Management LLC | 332,131 | $365.0K | 0.00% | −132,278−28.5% | Reduced |
| Acadian Asset Management LLC | 334,704 | $366.0K | 0.00% | +20,370+6.5% | Added |
| BlackRock Inc. | 517,559 | $569.0K | 0.00% | −7,997−1.5% | Reduced |
| Renaissance Technologies LLC | 730,598 | $804.0K | 0.00% | −172,502−19.1% | Reduced |
| Pivotal bioVenture Partners Investment Advisor LLC | 743,215 | $818.0K | 0.30% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 917,036 | $1.01M | 0.00% | +117,036+14.6% | Added |
| Newtyn Management, LLC | 1,000,000 | $1.10M | 0.24% | +37,912+3.9% | Added |
| Vanguard Group Inc | 1,089,992 | $1.20M | 0.00% | +27,320+2.6% | Added |
| Bank of America Corp | 1,148,142 | $1.26M | 0.00% | +10,371+0.9% | Added |
| Adage Capital Partners GP, L.L.C. | 1,473,278 | $1.62M | 0.00% | 00.0% | Unchanged |
| Tang Capital Management LLC | 1,674,166 | $1.84M | 0.23% | +126,456+8.2% | Added |
| Novo Holdings A/S | 1,950,000 | $2.15M | 0.10% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 2,076,400 | $2.28M | 0.01% | 00.0% | Unchanged |
| Versant Venture Management, LLC | 2,320,381 | $2.55M | 4.35% | 00.0% | Unchanged |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 2,365,064 | $2.60M | 0.07% | 00.0% | Unchanged |
| Vivo Capital, LLC | 3,547,030 | $3.90M | 0.43% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 3,948,360 | $4.34M | 0.13% | 00.0% | Unchanged |
| Boxer Capital, LLC | 0 | $0 | 0.00% | −1,526,048−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −73,986−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −58,392−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −48,045−100.0% | Sold out |
| Tri Locum Partners LP | 0 | $0 | 0.00% | −29,302−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −22,685−100.0% | Sold out |
| Wedmont Private Capital | 0 | $0 | 0.00% | −20,741−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −16,036−100.0% | Sold out |
| ETF Managers Group, LLC | 0 | $0 | 0.00% | −13,489−100.0% | Sold out |
| Hershey Trust Co | 0 | $0 | 0.00% | −4,552−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −2,933−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −169−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −11−100.0% | Sold out |